Invalid Specimen Study

Slides:



Advertisements
Similar presentations
Modifyuse bio. IB book IB Biology Topic 1: Statistical Analysis ary/Science/c4b/1/stat1.htm
Advertisements

ENGR 4296: Lecture 5, Slide 0 Dr. Keith Corzine: Simulation vs. Reality.
Module 14: Blood Collection and Handling Dried Blood Spot
Learning Objectives Collect Dried Blood Spots (DBS) for HIV testing
Studying a Study and Testing a Test: Sensitivity Training, “Don’t Make a Good Test Bad”, and “Analyze This” Borrowed Liberally from Riegelman and Hirsch,
Quality and Operations Management Process Control and Capability Analysis.
The Effect of Unsatisfactory Specimens on Newborn Screening Lisa Kalman, PhD Newborn Screening Quality Assurance Program, CDC.
Hemoglobin Electrophoresis
Hemoglobinopathies.
SCDAA 40 th Anniversary Convention 2012 Genetic Counseling for the Future Kwaku Ohene-Frempong, MD Children’s Hospital of Philadelphia Sickle Cell Foundation.
Vironostika® HIV-1 Plus O Microelisa System
Introduction Goal of this work is to better understand Guelph’s 2007 LibQUAL+ comments (in aggregate), within the context of the quantitative findings.
Reading the Dental Literature
Preliminary studies Imperfect bloodspots – what matters for the screening laboratory? UK Newborn Screening Laboratories Network Alex Lawson* Kate Hall.
Unsatisfactory Newborn Screening Specimens: Interpretations, Studies and Current Trends Presenters Dr. John Sherwin-California Health Department Dr. Ken.
Tobias, 2005Econometrics 472 Down’s Syndrome Example.
Overview of Newborn Screening Laboratory Processes and Quality Management Scott M. Shone, PhD Program Manager New Jersey NBS Laboratory SACHDNC May 11,
Concept of Measurement
Chapter 7 Analysis of ariance Variation Inherent or Natural Variation Due to the cumulative effect of many small unavoidable causes. Also referred to.
CHE 315 – Lecture 1 8/29/05 Introduction. Syllabus highlights.
Sampling and Data Collection
Enhanced Prenatal Screening Program
Genetic Counseling & Genetic Testing Katelyn Meadows & Betty Hagerman.
For Medical Clinical Staff WellOne Primary Medical and Dental Care Click here to move on.
Chemometrics Method comparison
Copyright c 2001 The McGraw-Hill Companies, Inc.1 Chapter 7 Sampling, Significance Levels, and Hypothesis Testing Three scientific traditions critical.
DATASET INTRODUCTION 1. Dataset: Urine 2 From Cleveland Clinic
Hemoglobin Electrophoresis
Continuity Clinic The Exciting, Emotional and often Misunderstood World of.
Analytical Goals. Valid data are essential in making medical decisions, the most important concepts used in judging analytical performance :- 1)Analytical.
The paired sample experiment The paired t test. Frequently one is interested in comparing the effects of two treatments (drugs, etc…) on a response variable.
Reliability of Screening Tests RELIABILITY: The extent to which the screening test will produce the same or very similar results each time it is administered.
TÜV SÜD AG 1 TL 9000 Measurements Auditing the Validation Process Jerry Wilson TL 9000 Program Manager / Lead Auditor TÜV SÜD America, Inc.
Quality Control Lecture 5
LT 4.2 Designing Experiments Thanks to James Jaszczak, American Nicaraguan School.
The nature of science. Scientific knowledge is the product of observation and inference. Observations and Inferences.
1 OTC-TFM Monograph: Statistical Issues of Study Design and Analyses Thamban Valappil, Ph.D. Mathematical Statistician OPSS/OB/DBIII Nonprescription Drugs.
Seed Germination Laboratory Report: Final Draft: Data Analysis Discussion and Conclusion.
· Lecture 31 & 32 : Scope of clinical biochemistry ط Uses of clinical biochemistry tests ط Diagnosis, Prognosis, Screening, Monitoring ط Reporting results.
5. Quality Assurance and Calibration Quality assurance is We do to get the right answer for our purpose. Have Sufficient accuracy and precision to support.
Analysis of Variance 1 Dr. Mohammed Alahmed Ph.D. in BioStatistics (011)
Human-Computer Interaction. Overview What is a study? Empirically testing a hypothesis Evaluate interfaces Why run a study? Determine ‘truth’ Evaluate.
Module 8: Blood Collection and Handling Dried Blood Spot
TYPE-SPECIFIC HUMAN PAPILLOMAVIRUS IN ENDOCERVIX, VAGINA, AND PERINEUM; IMPLICATIONS FOR VAGINAL SELF- COLLECTION Robert G. Pretorius, MD, Jerome L. Belinson,
Unit 8 Populations and Samples. What is a Sample? Sample = small subset of a population. Populations are the things that possess specific attributes –
Pompe Disease Evidence Evaluation Michael Watson, PhD, on behalf of Piero Rinaldo, MD, PhD, and the Decision-Making Workgroup October 1, 2008.
Missing Values Raymond Kim Pink Preechavanichwong Andrew Wendel October 27, 2015.
EBM --- Journal Reading Presenter :呂宥達 Date : 2005/10/27.
Section Conditional Probability Objectives: 1.Understand the meaning of conditional probability. 2.Learn the general Multiplication Rule:
NEWBORN BLOODSPOT - IMPROVING PRACTICE. Screening Tests Offered from 4 th Oct 2010: Phenylketonuria (PKU) Congenital Hypothyroidism (CHT)
MCADD, caused by mutation in the ACADM gene is the most common disorder of fatty acid  - oxidation. Treatment is very successfully if started before symptoms.
Abstract Systematic research on evaluation can greatly improve a program. But in making decisions about which evaluation model to choose, there needs to.
Performing a Medix Drug Test. 2 Equipment required for a Medix drug test 1.
Introduction to Quantitative Research
Mendel and the Gene Idea
Qualitative vs. Quantitative
Modify—use bio. IB book  IB Biology Topic 1: Statistical Analysis
Value of Information and other Decision Analytic Techniques for Optimization of Seismic and Drilling Mark Cronshaw SPEE Denver January 13, 2010 Gustavson.
الأستاذ المساعد بقسم المناهج وطرق التدريس
Process control in Hematology section
ISTE Workshop Research Methods in Educational Technology
Basic Concepts in Social Science Research
Chapter 10 Capillary Puncture Equipment and Procedure
Basic Concepts in Social Science Research
Practical Hematology Lab Hemoglobin Electrophoresis
Quality Assessment The goal of laboratory analysis is to provide the accurate, reliable and timeliness result Quality assurance The overall program that.
FECAL OCCULT BLOOD TESTING USING SERACULT SLIDES
Evidence Based Diagnosis
Sample Collection for POC EID
Emeril Santander Michael Kowalski Laure Tessier Jennifer Milburn
Presentation transcript:

Invalid Specimen Study Newborn Screening Program NYSDOH Joe Orsini, PhD Ken Pass, PhD

Full credit to the guy with the idea, and the talent and energy to make it happen: Joe Orsini, PhD

Valid Sample Completely fills circle Un-layered Un-smeared Homogeneous

Invalid Samples  addressed in this study Insufficient Quantity  1. Insufficient Quantity  Appears Scratched or abraded Not dried prior to mailing Supersaturated Diluted, discolored, or contaminated  Exhibits serum rings  Clotted or layered  No blood  addressed in this study 2. 3. 4. 5. 6. 7. 8.

Invalid Samples: NYS 2004* Quantity insufficient 492 15.4 % Invalid Type Samples Percentage Quantity insufficient 492 15.4 % Not dry before mailing 15 0.47 % Diluted, discolored, or contaminated 215 6.7 % Exhibits serum rings 1015 31.8 % Appears clotted or layered 543 17.0 % *Note, all specimens on card were identified as invalid, list does not include all invalid types counted.

Methodology Evaluate a single patient sample with valid/invalid DBS Pairs Punch sample pairs from invalid and valid sample Performed CAH, TSH, T4, Hgb, Biotinidase, Galactosemia, and MS/MS (AA/AC) tests Analyze data with Excel (Mean, Std. Dev., t-test, etc.) Compare data to valid sample pairs CAH, TSH, T4 – immunoassay PKU, MCADD – msms Hgb – electrophoresis Galactosemia – Beutler Biot. Def – Wolff test Example for invalid/valid pair: diluted, discolored or contaminated

Study Method: Pros and Cons Dependent on available samples Not all invalid types were available for this study Sometimes difficult to assign invalid sample type Unlikely for there to be both an abnormal baby and invalid sample type on same specimen Use real world specimens Invalid and valid samples collected at same time from same specimen Random sampling of DBS Invalid/valid sample pairs analyzed at same time

Testing Summary Qualitative tests Quantitative tests Heminoglobinopathies Biotinidase Galactosemia Quantitative tests CAH (17-OHP) CH (T4* and TSH) MCADD (C8*) PKU (phenylalanine*) * Example data shown, other tests showed similar data and are not presented on slides.

Invalid Samples - Study Invalid Type Samples Insufficient quantity 24 Diluted, discolored, contaminated 69 Exhibits serum rings 61 Specimen clotted or layered 180

Insufficient quantity Valid Sample Invalid Sample Note: on front side of card, all samples look acceptable

Insufficient quantity Phenylalanine High negative bias

Insufficient quantity MCADD/C8 High negative bias

Insufficient quantity Thyroxine High negative bias

Insufficient quantity summary Marker % Bias Phenylalanine -29.8 MCADD/C8 -15.3 CAH -25.8 TSH -19.5 Thyroxine -25 Overall negative bias Expected result with less blood T-test indicates high probability that invalid data sets are different from valid data sets (P<0.05) Potential for qualifying abnormal specimen as normal (opposite for T4)

Insufficient quantity Decision making Marker Valid Invalid Cutoff Report Valid Invalid CAH 10.6 7.5 ≥ 50 Normal Normal PKU 1.49 1.05 ≥ 4 Normal Normal MCADD 0.13 0.08 ≥ 0.8 T4 (CH) 12.5 2.8 ≤ 5 Normal Abnormal TSH (CH) 19.7 14.9 ≥ 18 Retest Normal

Diluted, Discolored, Contaminated Sample Valid Sample Invalid Sample

Diluted, discolored, contaminated Phenylalanine

Diluted, discolored, contaminated: MCADD/C8

Diluted, discolored, contaminated Thyroxine Ave Std Dev large for V/I pair

Diluted, discolored, contaminated Summary No difference in average bias for any marker MS/MS analytes – Valid/Invalid pairs indistinguishable Thyroxine: large variation in bias (-66 to 46), potential for false positives and negatives

Diluted, discolored, contaminated Decision making Marker Valid Invalid Cutoff Result Valid Invalid CAH 24.9 20.3 ≥ 50 Normal Normal PKU 0.97 1.21 ≥ 4 MCADD 0.17 0.14 ≥ 0.8 TSH (CH) 10.3 5.8 ≤ 5 17.4 20.6 ≥ 18 Normal Abnormal

Serum Rings Invalid Sample Valid Sample

Serum rings Phenylalanine

Serum rings MCADD/C8

Serum rings Thyroxine

Serum Rings Summary MS/MS analytes – Valid/Invalid pairs indistinguishable Thyroxine: large variation in bias for V/I pair compared to V/V pair (see min/max) No major difference in average bias for any marker

Serum Rings Decision making Marker Valid Invalid Cutoff Result Valid Invalid CAH 49.5 15.4 ≥ 50 Normal Normal PKU 1.03 1.73 ≥ 4 MCADD 0.16 0.11 ≥ 0.8 T4 10.3 16.9 ≤ 5 TSH (CH) 19.1 11.9 ≥ 18 Retest Normal

Clotted or Layered Invalid Sample (shows layered blood) Valid Sample

Clotted or layered Phenylalanine Note T-test show V/I data sets high probability of data sets being different

Clotted or layered MCADD/C8 Note T-test show V/I data sets high probability of data sets being different

Clotted or layered Thyroxine

Clotted or layered Summary Overall Positive bias Some specimens w/ large neg. bias results Potential to have false positives and false negatives Expected due to layering of blood Marker Average % Bias 17-OHP 9.8 Phenylalanine 8.8 MCADD/C8 6.7 TSH 14.2 Thyroxine 9.3

Clotted or layered: Decision making Marker Valid Invalid Cutoff Result Valid Invalid CAH 50.2 39.3* ≥ 50 Retest Normal PKU 0.76 0.96 ≥ 4 Normal Normal MCADD 0.09 0.11 ≥ 0.8 T4 18.5 20.1 ≤ 5 TSH 7.7 19 ≥ 18 Normal Retest 19.1 11.9 Retest Normal *Invalid result lower than valid specimen result

Summary

Qualitative tests: valid/invalid samples indistinguishable N - Normal, AC - C-trait , AF - A>F , AFE - fetal variant , AS - Sickle trait , FST - J, N, or Bart’s variant

Quantitative Data: Effect on Decision Making Test 17-OHP Phe C8 T4 TSH Galac Biotin Hgb signal ↑ ↓ P/A QNS FN FP N/A Diluted FN/FP Rings Clotted/layered P/A = present/absent, FN = False Neg., FP = False Positive

Decision making data summary: Conclusions Quantity Insufficient Bias low results, may be false negative or false Positive (T4) Qualitative results were unaffected (however, only 24 points and no positive specimens were tested) Decision making data summary:

Decision making data summary: Conclusions Diluted, discolored, or contaminated MS analytes largely unaffected Qualitative results unaffected (however, no positive specimens were tested) T4 and TSH results show large variation in measured bias for V/I pair Decision making data summary:

Decision making data summary: Conclusions Serum Rings MS analytes largely unaffected, however there are affected samples (see below) Qualitative results unaffected (however, no positive specimens were tested) T4 and TSH results show large variation in measured bias for V/I sample pair Decision making data summary:

Decision making data summary: Conclusions Clotted or layered Bias high results, may be false negative (T4) or false Positive Qualitative results were unaffected (however, no positive specimens were tested) Decision making data summary:

Conclusions Quantity Insufficient Diluted, discolored, or contaminated Bias Low results for quantitative tests (false neg. - except T4) Qualitative tests unaffected Diluted, discolored, or contaminated MS analytes largely unaffected T4 and TSH results show large variation in bias for V/I pair (+/-) Qualitative results unaffected Serum Rings Clotted or layered Generally bias high results, may be false negative (T4) or false positive Some bias low results (where blood has not been layered)

Urban Legend vs. Reality Invalid ok Galactosemia Hgb Biotinidase Invalid NOT ok CH CAH MCAD PKU

Thank you.